Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
ESH 2016 - 3rd International Conference on Multiple Myeloma
7 - 9 Oct 2016
TBC, Milan, Italy
Overcoming painful bone disease in myeloma
Dr Nicola Giuliani - University of Parma, Parma, Italy
2 Nov 2016
History and progress of CD38 in myeloma
Dr Fabio Malavasi - University of Turin, Turin, Italy
2 Nov 2016
Maintenance therapy in young myeloma patients beneficial after autologous stem c...
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
2 Nov 2016
Better doctor-patient communication needed to improve myeloma outcomes
Dr Karthik Ramasamy - Oxford University Hospital, Oxford, UK
2 Nov 2016
History of antiangiogenic drugs in multiple myeloma, starting with thalidomide
Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany
2 Nov 2016
Elderly patients should be treated based on biological age, not chronological
Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienn...
2 Nov 2016
Cancer or amyloidosis?
Dr Giovanni Palladini - Director, Amyloidosis Research and Treatment Center, Pav...
2 Nov 2016
Monoclonal antibodies in multiple myeloma
Dr Phillippe Moreau - University Hospital of Nantes, Nantes, France
1 Nov 2016
How can we make the best decisions for health whilst considering cost?
Dr Andrea Manca - University of York, York, UK
1 Nov 2016
Preemptively treating patients most at risk of progression to myeloma
Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain
1 Nov 2016
Drug combos with daratumumab likely to become standard of care in myeloma
Dr Niels Van De Donk - VU University Medical Center, Amsterdam, Holland
1 Nov 2016
Overview of the CD38 antibody in multiple myeloma
Dr Torben Plesner - Vejle Hospital, Vejle, Denmark
1 Nov 2016
New drugs and combinations in haematological cancers improve complete remission ...
Dr Paolo Corradini - University of Milan, Milan, Italy
1 Nov 2016
Benefits and problems of allogeneic stem cell transplantation as multiple myelom...
Prof Nicolaus Kröger - University Hospital Hamburg, Hamburg, Germany
1 Nov 2016
